Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Parkinson's Disease
Parkinson's Disease
Sage Axes Parkinson’s Program for Dalzanemdor After Phase II Flop
BioSpace
Wed, 04/17/24 - 11:23 am
SAGE Therapeutics
clinical trials
Parkinson's Disease
dalzanemdor
AbbVie-backed effort spotlights night symptoms of Parkinson’s
Medical Marketing and Media
Thu, 04/11/24 - 10:15 pm
Parkinson's Disease
AbbVie
public awareness
FDA swats away Supernus’ Parkinson’s disease infusion pump for 3rd time
Fierce Pharma
Mon, 04/8/24 - 11:07 am
Medtech
FDA
Supernus
Parkinson's Disease
Parkinson’s disease may be helped by GLP-1 drug, new study finds
Stat
Wed, 04/3/24 - 10:41 pm
GLP-1 agonist
Parkinson's Disease
lixisenatide
Photopharmics kickstarts phototherapy trial for Parkinson’s disease
Clinical Trials Arena
Thu, 03/28/24 - 11:15 am
Photopharmics
phototherapy
Medtech
clinical trials
Parkinson's Disease
Cure Ventures backs a cell therapy startup targeting Parkinson’s
BioPharma Dive
Thu, 02/29/24 - 06:58 pm
Kenai Therapeutics
cell therapy
Parkinson's Disease
funding
Cure Ventures
AbbVie introduces Produodopa for advanced Parkinson’s in EU
Pharmaceutical Business Review
Wed, 01/10/24 - 09:31 am
AbbVie
Produodopa
Parkinson's Disease
Europe
Bayer's AskBio checks off another early win for gene therapy platform with Parkinson's safety data
Fierce Biotech
Thu, 01/4/24 - 10:12 am
Bayer
AskBio
gene therapy
Parkinson's Disease
Enrollment starts in trial of AI-powered Parkinson’s therapy
Pharmaphorum
Fri, 12/15/23 - 09:39 am
Parkinson's Disease
Newel Health
clinical trials
digital therapeutics
Medtech
artificial intelligence
Potential FDA approval for Supernus’s SPN-830 in Parkinson’s but challenges remain
Clinical Trials Arena
Mon, 10/16/23 - 10:18 am
Supernus
SPN-830
Parkinson's Disease
FDA
Stem Pharm and Verge Genomics Form Collaboration Focused on Parkinson’s Disease
BioSpace
Tue, 10/10/23 - 10:12 am
Stem Pharm
Verge Genomics
Parkinson's Disease
artificial intelligence
Months after FDA slam, AbbVie buys Parkinson’s disease drugmaker Mitokinin
Medical Marketing and Media
Thu, 10/5/23 - 09:15 pm
AbbVie
M&A
Mitokinin
Parkinson's Disease
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
MedCity News
Mon, 08/28/23 - 08:21 pm
Bayer
cell therapy
Parkinson's Disease
clinical trials
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Fierce Biotech
Mon, 08/28/23 - 11:37 am
Bayer
Parkinson's Disease
cell therapy
bemdaneprocel
BlueRock Therapeutics
Aspen taps tech firms for digital Parkinson's trial
Pharmaphorum
Fri, 08/25/23 - 09:45 am
Apen Neuroscience
Parkinson's Disease
cell therapy
Emerald Innovations
Rune Labs
Bayer-bought BlueRock cuts 12% of workforce across 3 sites as pipeline contracts
Fierce Biotech
Thu, 08/17/23 - 11:32 pm
BlueRock Therapeutics
Parkinson's Disease
Bayer
layoffs
Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease
BioSpace
Mon, 07/24/23 - 09:57 am
neurodegenerative disease
Alzheimer's disease
Axsome Therapeutics
Eli Lilly
Anavex
TauRx
AB Science
ALS
BrainStorm Cell Therapeutics
Seelos Therapeutics
Parkinson's Disease
AbbVie
Mitsubishi Tanabe Pharma
Annovis
Huntington's disease
Prilenia Therapeutics
Neurocrine
Boston Scientific’s New Deep Brain Stimulation Software Gets FDA Nod
Xtalks
Mon, 07/17/23 - 09:13 am
Boston Scientific
Medtech
deep brain stimulation
Vercise Deep Brain Stimulation System
FDA
Parkinson's Disease
Amneal’s long-acting Parkinson’s drug gets cold shoulder from FDA
Medical Marketing and Media
Wed, 07/5/23 - 07:03 pm
Amneal Pharmaceuticals
FDA
Parkinson's Disease
IPX203
Bayer's Parkinson's cell therapy passes early clinical safety test, clearing path to phase 2
Fierce Biotech
Wed, 06/28/23 - 10:05 am
Bayer
Parkinson's Disease
clinical trials
cell therapy
bemdaneprocel
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »